On this page
Sevenfact
coagulation factor VIIa (recombinant)-jncw
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Sevenfact
Proper name
coagulation factor VIIa (recombinant)-jncw
Licence type
351(a)
BLA number
125641
Applicant
Laboratoire Francais du Fractionnement et des Biotechnologies S.A.
Center
CBER
Presentations
3
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 1MG | Injection | Intravenous | Single-Dose Vial | Rx | April 1, 2020 |
| 2MG | Injection | Intravenous | Single-Dose Vial | Disc | June 20, 2024 |
| 5MG | Injection | Intravenous | Single-Dose Vial | Rx | April 1, 2020 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |